SK bioscience

본문바로가기

KOR ENG

sitemap

PR

SK bioscience company news updates

Press Releases

SK bioscience’s Quadrivalent Influenza Vaccine Achieved Approval by the Ministry of Food and Drug Safety for Infant Use

2020. 06. 23
SK bioscience Receives Fund for COVID-19 Vaccine Development

2020. 05. 18
SK bioscience-Sanofi Pasteur Suubmit IND Amendment for Phase II Global Clinical Trial of Next-Generation Pneumococcal Conjugate Vaccine

2020. 03. 30
SK biosicnece Enters Animal Testing Stage Of COVID-19 Vaccine

2020. 03. 24
SK bioscience Is Chosen As Partner for National Project of Developing COVID-19 Vaccine Candidate

2020. 03. 18
SK bioscience´s Shingles Vaccine Sales Exceed 1 Million Doses Two Years After Launch

2020. 03. 12
SK bioscience Initiates Development of New Vaccine Platform Against Vartiants in Response to New Infectious Diseases

2020. 02. 24
SK bioscience Receives WHO PQ of Cell Culture-Based Quadrivalent Influenza Vaccine

2020. 01. 02
SK bioscience’s Varicella Vaccine Obtains World’s 2nd WHO PQ Certification

2019. 12. 11
SK bioscience Wins the 2019 Medical Korea Grand Prize

2019. 11. 21
SK bioscience´s Influenza Vaccine Receives The First Place in Vaccine Category of ‘2019 Korea Highest Brand.’

2019. 10. 30
SK bioscience Won the Andong Mayor`s Award for Contributing Social Value Connected With the Region

2019. 10. 30